ARTICLE SYNOPSIS...Aastrom Biosciences, Inc. (ASTM) is developing automated clinical systems designed to enable therapeutic procedures using living cells in the treatment of cancer and other diseases and in the restoration of normal tissues.
ARTICLE SYNOPSIS...This stock was worth watching in September 2004. The price then was $0.92. Had you bought...